Prognostic Factors, Treatment, and Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era

被引：0
|
作者：
Hiniker, S. M. [1 ]
Pollom, E. L. [1 ]
Khodadoust, M. S. [1 ]
Kozak, M. M. [1 ]
Advani, R. H. [1 ]
Hoppe, R. T. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3185
引用
收藏
页码：S677 / S678
页数：2
相关论文
共 50 条
  • [31] Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era
    Kumar, Anita
    Lunning, Matthew A.
    Zhang, Zhigang
    Migliacci, Jocelyn C.
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) : 776 - 783
  • [32] Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era.
    Hiniker, Susan M.
    Pollom, Erqi L.
    Khodadoust, Michael S.
    Kozak, Margaret M.
    Advani, Ranjana H.
    Hoppe, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Outcomes of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Salvage Chemotherapy and Intention to Transplant in the Rituximab Era
    Vardhana, Santosha A.
    Moskowitz, Craig H.
    Sauter, Craig S.
    Matasar, Matthew J.
    Galasso, Natasha
    Woo, Kaitlin M.
    Zhang, Zhigang
    BLOOD, 2015, 126 (23)
  • [34] Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Vardhana, Santosha A.
    Sauter, Craig S.
    Matasar, Matthew J.
    Zelenetz, Andrew D.
    Galasso, Natasha
    Woo, Kaitlin M.
    Zhang, Zhigang
    Moskowitz, Craig H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 591 - 599
  • [35] Abbreviated chemotherapy for limited-stage diffuse large B-cell lymphoma after complete resection
    Jo, Jungmin
    Yoon, Dok Hyun
    Lee, Sang Wook
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Kyoungmin
    Kang, Eun Hee
    Kim, Shin
    Suh, Cheolwon
    BLOOD RESEARCH, 2014, 49 (02) : 115 - 119
  • [36] Do We Have the Right Prognostic Index for Diffuse Large B Cell Lymphoma (DLBCL) in the Era of Rituximab?
    Tai, W. M.
    Tang, P. L.
    Koo, Y. X.
    Hou, X.
    Tay, K. W.
    Quek, R.
    Tao, M.
    Lim, S. T.
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2011, 20 (01) : 48 - 54
  • [37] Diffuse large B-cell lymphoma (DLBCL)
    Renner, C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S10 - S10
  • [38] PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Yoon, S.
    Yoon, D. H.
    Kim, S.
    Lee, K.
    Kang, E. H.
    Lee, S. W.
    Park, C. J.
    Park, C. S.
    Huh, J.
    Suh, C.
    HAEMATOLOGICA, 2015, 100 : 403 - 404
  • [39] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [40] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
12345